Adaptimmune Therapeutics shares owned by Rathbones Brothers
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Rathbones Brothers
from 13F filings
Historical chart of Rathbones Brothers investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Rathbones Brothers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Rathbones Brothers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $422k | 433k | 0.97 |
| 2024-03-31 | $684k | 433k | 1.58 |
| 2023-09-30 | $338k | 433k | 0.78 |
| 2023-06-30 | $400k | 433k | 0.93 |
| 2023-03-31 | $472k | 433k | 1.09 |
| 2022-12-31 | $632k | 433k | 1.46 |
| 2022-09-30 | $465k | 433k | 1.07 |
| 2022-06-30 | $736k | 433k | 1.70 |
| 2022-03-31 | $892k | 433k | 2.06 |
| 2021-12-31 | $1.6M | 433k | 3.75 |
| 2021-09-30 | $2.2M | 433k | 5.17 |
| 2021-06-30 | $1.8M | 433k | 4.26 |
| 2021-03-31 | $2.3M | 433k | 5.31 |
| 2020-12-31 | $2.3M | 433k | 5.39 |
| 2020-09-30 | $3.5M | 433k | 7.98 |
| 2020-06-30 | $4.4M | 443k | 10.01 |
| 2020-03-31 | $1.1M | 399k | 2.72 |
| 2019-12-31 | $843k | 703k | 1.20 |
| 2019-09-30 | $1.1M | 703k | 1.51 |
| 2019-06-30 | $2.8M | 705k | 4.02 |
| 2019-03-31 | $1.2M | 286k | 4.30 |
| 2018-12-31 | $1.3M | 223k | 5.75 |
| 2018-09-30 | $3.0M | 223k | 13.56 |
| 2018-06-30 | $2.9M | 243k | 11.87 |
| 2018-03-31 | $2.7M | 243k | 11.23 |
| 2017-12-31 | $2.1M | 313k | 6.68 |
| 2017-09-30 | $2.6M | 321k | 8.19 |
| 2017-06-30 | $900k | 201k | 4.49 |
| 2017-03-31 | $1.1M | 201k | 5.51 |
| 2016-12-31 | $812k | 201k | 4.05 |
| 2016-09-30 | $2.3M | 330k | 7.05 |
| 2016-06-30 | $3.7M | 451k | 8.15 |
| 2016-03-31 | $1.6M | 201k | 8.13 |
| 2015-12-31 | $1.5M | 201k | 7.55 |